1. Home
  2. SLNG vs CUE Comparison

SLNG vs CUE Comparison

Compare SLNG & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$4.27

Market Cap

92.0M

Sector

Utilities

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.31

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
CUE
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
49.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SLNG
CUE
Price
$4.27
$0.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$3.00
AVG Volume (30 Days)
6.6K
1.2M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$72,270,000.00
$7,100,000.00
Revenue This Year
$7.02
N/A
Revenue Next Year
$7.68
$25.00
P/E Ratio
$76.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.29
$0.23
52 Week High
$8.28
$1.75

Technical Indicators

Market Signals
Indicator
SLNG
CUE
Relative Strength Index (RSI) 35.71 33.29
Support Level $4.10 $0.23
Resistance Level $4.38 $0.33
Average True Range (ATR) 0.22 0.05
MACD -0.08 -0.01
Stochastic Oscillator 15.61 26.85

Price Performance

Historical Comparison
SLNG
CUE

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: